Tobramycin

Spezifikationen

32986-56-4CAS-Nummer

251-322-5EG-Nummer

(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diolIUPAC-Name

C18H37N5O9Chemische Formel

467.5 g/molMolekulargewicht

tobramycin; 32986-56-4; Nebramycin VI; Nebramycin 6; Nebramycin factor 6; Deoxykanamycin B; Tobrex; Tobi; 3'-Deoxykanamycin B; Aktob; Tobralex; Tobi Podhaler; vantobra; Tobramicina; Tobramycine; Obramycin; 1-Epitobramycin; Tobramycetin; Tobramycinum; Bethkis; Kitabis Pak; Tobramitsetin; Tenebrimycin; Tenemycin; Nebicin; DTXSID8023680; VZ8RRZ51VK; NSC-180514; (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol; DTXCID903680; CHEBI:28864; 4-(2,6-Diamino-2,3,6-trideoxy-alpha-D-glycopyranosyl)-6-(3-amino-3-deoxy-alpha-D-glycopyranosyl)-2-deoxystreptamine; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-4))-2-deoxy-; O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine; Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-tyrideoxy-alpha-D-ribohexopyranosyl-(1-6))-2-deoxy-, D-; O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine; Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-6))-2-deoxy-, D-; Bramitob; Tobravisc; Tymbrineb; Nebris; Tobramycin solution; (2S,3R,4S,5S,6R)-4-amino-2-((1S,2S,3R,4S,6R)-4,6-diamino-3-((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl)oxy-2-hydroxycyclohexyl)oxy-6-(hydroxymethyl)oxane-3,5-diol; O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4)]-2-deoxy-D-streptamine; Tobramycin Inhalation; RefChem:6312; Tobramycin Inhalation Solution; Tobramycin Ophthalmic Solution; J01GB01; S01AA12; Tobramycin Inhalation Solution Pak; 251-322-5; 3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->4))-2-deoxy-D-streptamine; Tobramicin; Tobramycin Base; Tobramycin Deuterated; Tobracin (TN); Tobrex (TN); C18H37N5O9; NSC 180514; (2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol; Gotabiotic; Tobacin; Tobrased; (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol; (2S,3R,4S,5S,6R)-4-amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol; Tobramycine [INN-French]; Tobramycinum [INN-Latin]; Tobramicina [INN-Spanish]; (1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside; O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-->6)-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-->4)]-2-deoxy-D-streptamine; TOY; Nebramycin factir 6; HSDB 3259; SR-05000001726; EINECS 251-322-5; UNII-VZ8RRZ51VK; MFCD00077885; SPRC-AB01; BRN 1357507; torbamycin; Kitabis; Nebramycin Factor 6;Deoxykanamycin B; Tobramycin CRS; Nebcin (Sulfate); NCGC00016814-01; D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(2,6-DIAMINO-2,3,6-TRIDEOXY-.ALPHA.-D-RIBO-HEXOPYRANOSYL-(1->4))-2-DEOXY-; D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1->4)]-2-deoxy-; Bethkis (TN); CAS-32986-56-4; AT02 - Tobramycin; Tobramycin [USAN:USP:INN:BAN:JAN]; Tobi (TN); Tobramycin, Free Base; Spectrum_001072; TOBRAMYCIN [MI]; TOBRAMYCIN [INN]; TOBRAMYCIN [JAN]; Prestwick3_000544; Spectrum2_000078; Spectrum3_000588; Spectrum4_000752; Spectrum5_001038; Tobramycin - high purity; TOBRAMYCIN [HSDB]; TOBRAMYCIN [USAN]; TOBRAMYCIN [VANDF]; Tobramycin (JP18/USP); SCHEMBL2838; TOBRAMYCIN [MART.]; CHEMBL1747; TOBRAMYCIN [USP-RS]; TOBRAMYCIN [WHO-DD]; BSPBio_000587; BSPBio_002036; KBioGR_001104; KBioSS_001552; MLS000069544; BIDD:GT0503; SPECTRUM1500579; SPBio_000295; BPBio1_000647; orb1225291; orb1309215; orb3140193; Tobramycin Deuterated (>90%); TOBRAMYCIN [ORANGE BOOK]; GTPL10930; KBio2_001552; KBio2_004120; KBio2_006688; KBio3_001536; ZYLET COMPONENT TOBRAMYCIN; MSK7708; TOBRAMYCIN [EP MONOGRAPH]; Tobramycin for identification CRS; GLXC-06548; HMS2090B16; HMS2092M17; HMS2096N09; HMS3713N09; Pharmakon1600-01500579; TOBRAMYCIN [USP MONOGRAPH]; HY-B0441; TOBRADEX COMPONENT TOBRAMYCIN; Tox21_110626; BDBM50366778; CCG-39936; EBC-27168; HB4564; MSK7708-100W; NSC757352; s2514; TOBRASONE COMPONENT TOBRAMYCIN; Tobradex (tobramycin + dexamethasone); AKOS016339662; MSK7708-1000W; DB00684; KS-1405; NSC-757352; TOBRADEX ST COMPONENT TOBRAMYCIN; NCGC00178852-01; NCGC00178852-02; NCGC00178852-17; Tobramycin Solution in Water, 100ug/mL; AT161114; O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-6))-2-deoxy-L-streptamine; SMR000058793; SBI-0051915.P003; Tobramycin Solution in Water, 1000ug/mL; Second International Standard for Tobramycin; AB00513858; NS00003131; T5604; C00397; D00063; AB00052438-12; AB00052438_13; AB00052438_14; EN300-7480857; F863874; SR-01000721898; Tobramycin, Antibiotic for Culture Media Use Only; Q-201837; Q1758380; SR-01000721898-2; SR-05000001726-1; SR-05000001726-2; BRD-K05619559-001-10-1; BRD-K05619559-001-12-7; (1S,2S,3R,4S,6R)-4,6-diamino-3-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside; D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribohexopyranosyl-(1->4)]-2-deoxy-; D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1?6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1?4)]-2-deoxy-; O-[3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)]-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->4)]-2-deoxy-D-streptamine; O-[3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1?6)]-O-[2,6-diamino-2,3 ,6-trideoxy-alpha-D-ribohexopyranosyl-(1?4)]-2-deoxy-D-streptamine; O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(2,6-DIAMINO-2,3,6-TRIDEOXY-.ALPHA.-D-RIBO-HEXOPYRANOSYL-(1.ALPHA.6))-2-DEOXY-L-STREPTAMINE; O-3-Amino-3-deoxy-|A-D-glucopyranosyl-(1 inverted exclamation marku6)-O-[2,6-diamino-2,3,6-trideoxy-|A-D-ribo-hexopyranosyl-(1 inverted exclamation marku4)]-2-deoxy-D-streptamineSynonyme